Ankylosing spondylitis
Conference Coverage
Consider centralized pain in patients with rheumatic disease
LAS VEGAS – Every patient with chronic pain should complete a fibromyalgia survey, Dr. Daniel J. Clauw says.
Latest News
Secukinumab continues promising axial spondyloarthritis results in PREVENT
Results from 52 weeks showed significantly greater improvement among patients taking secukinumab for nonradiographic disease, compared with...
From the Journals
Continuous NSAID use for ankylosing spondylitis may raise hypertension risk
Prospective cohort study results help to resolve findings from previous studies that left unclear results about NSAIDs’ hypertensive effects on...
From the Journals
Collagen metabolites show biomarker potential in axial spondyloarthritis
Serum levels of four collagen metabolites show promising signs of being biomarkers for disease activity in axial spondyloarthritis patients.
Feature
Prior authorizations for infusibles cause delays, toxicities
A new study reveals the prior authorization difficulties that patients must go through to receive infusible biologics, providing evidence to...
From the Journals
Ankylosing spondylitis severity, comorbidities higher in blacks than in whites
The main differences were in erythrocyte sedimentation rates and C-reactive protein, as well as prevalence of anterior uveitis, hypertension,...
From the Journals
Two uveitis treatment options yield similar success
Methotrexate and mycophenolate mofetil were similarly effective for corticosteroid-sparing in uveitis patients.
From the Journals
Cannabidiol may interact with rheumatologic drugs
CBD is known to inhibit the cytochrome P450 enzymes that metabolize corticosteroids and other medications.
Guidelines
Axial SpA guidelines updated with best practices for new drugs, imaging
Changes to the guidelines largely center on use of interleukin-17 inhibitors, tofacitinib, and biosimilars of tumor necrosis factor–alpha...
News from the FDA/CDC
FDA approves Taltz for treatment of ankylosing spondylitis
The approval is based on results from a pair of randomized, double-blind, placebo-controlled, phase 3 studies involving 657 adult patients with...
Conference Coverage
EULAR updates vaccination recommendations for autoimmune inflammatory rheumatic disease patients
EULAR’s updated guidance on vaccinations for patients with AIIRD starts with an annual status assessment.